The current health expenditure in South Africa for 2023 stood at 1.21 thousand US dollars PPP per capita. Forecasted data for 2024 indicates a slight increase to 1.23, and the upward trend continues through to 2028, where it is expected to reach 1.29. Year-on-year variation shows incremental increases of approximately 1.63% in 2025, 0.80% in 2026, 1.59% in 2027, and 0.78% in 2028. Over the last two years: 2023 to 2024 (1.65%), 2024 to 2025 (1.63%). The compound annual growth rate (CAGR) over the five-year forecast period is approximately 1.28%.
Future trends to watch for include potential impacts of inflation, government healthcare policies, and the economic situation in South Africa. It's also essential to monitor global health trends and their influence on local healthcare expenditure. Any significant technological advancements or changes in the healthcare delivery model, such as increased adoption of telemedicine, could further affect these projections.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...